About biotechnology application, Biotech Summit Advisory Board

Sports / Entertainment


Wall St. whistleblower faces $10.7M hit

Posted on September 03, 2010 by admin

Wall St. whistleblower faces $10.7M hit
It doesn’t pay to be a Wall Street whistleblower. At least that’s the lesson for former Rodman & Renshaw biotech analyst Matthew Murray, who was told last month to pay his ex-employer a whopping $10.7 million by the Financial Industry Regulatory Authority. “I thought that after the Wall…

Read more on New York Post

Leave a Reply




↑ Top

Powered by Yahoo! Answers